title: Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
abstract: Live-attenuated retroviruses have been shown to be effective retroviral vaccines, but currently little is known regarding the mechanisms of protection. In the present studies, we used Friend virus as a model to analyze characteristics of a live-attenuated vaccine in protection against virus-induced disease. Highly susceptible mice were immunized with nonpathogenic Friend murine leukemia helper virus (F-MuLV), which replicates poorly in adult mice. Further attenuation of the vaccine virus was achieved by crossing the Fv-1 genetic resistance barrier. The minimum dose of vaccine virus required to protect 100% of the mice against challenge with pathogenic Friend virus complex was determined to be 10(3) focus-forming units of attenuated virus. Live vaccine virus was necessary for induction of immunity, since inactivated F-MuLV did not induce protection. To determine whether immune cells mediated protection, spleen cells from vaccinated donor mice were adoptively transferred into syngeneic recipients. The results indicated that immune mechanisms rather than viral interference mediated protection.
authors.affiliation: Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840, USA. udittmer@atlas.niaid.nih.gov
authors.forename: U
authors.initials: U
authors.lastname: Dittmer
authors.forename: D M
authors.initials: DM
authors.lastname: Brooks
authors.forename: K J
authors.initials: KJ
authors.lastname: Hasenkrug
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D005622:Friend murine leukemia virus / Q000276:immunology*; D007942:Leukemia, Experimental / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D009500:Neutralization Tests; D012192:Retroviridae Infections / Q000276:immunology / Q000517:prevention & control*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control*; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*; D014766:Viremia / Q000276:immunology / Q000517:prevention & control
chemical_list: D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines